FI971777L - Katepsiini O2-proteaasi - Google Patents

Katepsiini O2-proteaasi Download PDF

Info

Publication number: FI971777L
Authority: FI; Finland
Prior art keywords: cathepsin; protease
Prior art date: 1994-10-27

Application number

FI971777A

Other languages

English (en)

Swedish (sv)

Other versions

FI971777A7 (fi

FI971777A0 (fi

Inventor

Dieter Broemme

Kathleen Okamoto

Original Assignee

Arris Pharm Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-27

Filing date

1995-10-26

Publication date

1997-04-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26987129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI971777(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-27 Priority claimed from US08/330,121 external-priority patent/US5736357A/en

1995-10-26 Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp

1997-04-25 Publication of FI971777A7 publication Critical patent/FI971777A7/fi

1997-04-25 Publication of FI971777L publication Critical patent/FI971777L/fi

1997-04-25 Publication of FI971777A0 publication Critical patent/FI971777A0/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6472—Cysteine endopeptidases (3.4.22)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Virology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
Enzymes And Modification Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI971777A 1994-10-27 1995-10-26 Katepsiini O2-proteaasi FI971777A0 (fi)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US08/330,121 US5736357A (en)	1994-10-27	1994-10-27	Cathespin O protease
US08/536,861 US6544767B1 (en)	1994-10-27	1995-10-02	Cathespin O2 protease
PCT/US1995/013820 WO1996013523A1 (en)	1994-10-27	1995-10-26	Cathepsin o2 protease

Publications (3)

Publication Number	Publication Date
FI971777A7 FI971777A7 (fi)	1997-04-25
FI971777L true FI971777L (fi)	1997-04-25
FI971777A0 FI971777A0 (fi)	1997-04-25

Family

ID=26987129

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI971777A FI971777A0 (fi)	1994-10-27	1995-10-26	Katepsiini O2-proteaasi

Country Status (15)

Country	Link
US (2)	US6544767B1 (fi)
EP (1)	EP0783527B1 (fi)
JP (1)	JP3670666B2 (fi)
KR (1)	KR100473219B1 (fi)
CN (1)	CN1148382C (fi)
AT (1)	ATE317441T1 (fi)
AU (1)	AU711810B2 (fi)
CA (1)	CA2203765C (fi)
DE (1)	DE69534778T2 (fi)
ES (1)	ES2256849T3 (fi)
FI (1)	FI971777A0 (fi)
HU (1)	HU220960B1 (fi)
NO (1)	NO971875L (fi)
NZ (1)	NZ296003A (fi)
WO (1)	WO1996013523A1 (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6403304B1 (en)	1993-04-06	2002-06-11	Forsyth Dental Infirmary For Children	Human osteoclast-specific and -related DNA sequences
US5501969A (en)	1994-03-08	1996-03-26	Human Genome Sciences, Inc.	Human osteoclast-derived cathepsin
AU711014B2 (en)	1995-10-30	1999-10-07	Smithkline Beecham Corporation	Method of inhibiting cathepsin K
US6586466B2 (en)	1995-10-30	2003-07-01	Smithkline Beecham Corporation	Carbohydrazide-protease inhibitors
TR199800767T2 (xx)	1995-10-30	1998-07-21	Smithkline Beecham Corporation	Proteaz engelleyicileri.
EP0812916A3 (en) *	1996-06-14	1998-12-09	Smithkline Beecham Corporation	Cathepsin k gene
WO1998000716A1 (en) *	1996-07-03	1998-01-08	Novadx, Inc.	Method for detecting degenerative bone disease
GB9701888D0 (en) *	1997-01-30	1997-03-19	Ciba Geigy Ag	Novel methods
US5948669A (en) *	1997-02-26	1999-09-07	Smithkline Beecham Corporation	Rat cathepsin K polynucleotide and polypeptide sequence
US20030144175A1 (en)	1998-12-23	2003-07-31	Smithkline Beecham Corporation	Protease inhibitors
US6346373B1 (en) *	1999-05-05	2002-02-12	Merck Frosst Canada & Co.,	Whole cell assay for cathepsin K activity
WO2001000798A2 (en) *	1999-06-25	2001-01-04	Hybritech Incorporated	Cloning and expressing of human cathepsin k in mammalian cells
EP1229914A4 (en)	1999-11-10	2004-06-23	Smithkline Beecham Corp	PROTEASE INHIBITORS
EP1232154A4 (en)	1999-11-10	2004-06-23	Smithkline Beecham Corp	PROTEASE INHIBITORS
WO2001034599A1 (en)	1999-11-10	2001-05-17	Smithkline Beecham Corporation	Protease inhibitors
AU780364B2 (en)	2000-01-20	2005-03-17	Merck Sharp & Dohme Corp.	Alpha V integrin receptor antagonists
JP2003527429A (ja)	2000-03-21	2003-09-16	スミスクライン・ビーチャム・コーポレイション	プロテアーゼ阻害物質
AU2002239753A1 (en) *	2000-10-18	2002-05-21	Incyte Genomics, Inc.	Proteases
CN100408681C (zh) *	2002-06-17	2008-08-06	株式会社日冷	来源于粉红色虾的新型组织蛋白酶l样半胱氨酸蛋白酶
US7101880B2 (en) *	2002-06-24	2006-09-05	Schering Aktiengesellschaft	Peptidic compounds as cysteine protease inhibitors
JP2006528151A (ja) *	2003-07-21	2006-12-14	ノバルティスアクチエンゲゼルシャフト	骨転移、腫瘍増殖および腫瘍誘発骨量減少の処置におけるカテプシンｋ阻害剤およびビスホスホネートの組み合わせ
US7312353B2 (en)	2003-08-21	2007-12-25	Merck Frost Canada & Co.	Cathespin cysteine protease inhibitors
CA2539076A1 (en) *	2003-09-23	2005-03-31	Merck Frosst Canada Ltd.	Whole cell assay for inhibitors of cathepsin k
WO2005093421A1 (de) *	2004-03-10	2005-10-06	Biovendor Laboratory Medicine, Inc.	Enzymimmunoassay zur bestimmung von cathepsin k
US7029902B2 (en) *	2004-03-26	2006-04-18	Applera Corporation	Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
TWI395593B (zh) *	2008-03-06	2013-05-11	Halozyme Inc	可活化的基質降解酵素之活體內暫時性控制
AU2013202011C1 (en) *	2008-03-06	2015-10-01	Halozyme, Inc.	In vivo temporal control of activatable matrix-degrading enzymes
LT2953948T (lt)	2013-02-07	2018-01-10	Scifluor Life Sciences, Inc	Fluorinti integrino antagonistai
US8901144B2 (en)	2013-02-07	2014-12-02	Scifluor Life Sciences, Llc	Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
JP6649902B2 (ja)	2014-05-30	2020-02-19	ファイザー・インク	選択的アンドロゲン受容体モジュレーターとしてのカルボニトリル誘導体
RU2017132433A (ru)	2015-02-19	2019-03-19	Сайфлуор Лайф Сайенсиз, Инк.	Фторированные производные тетрагидронафтиридинилнонановой кислоты и их применение
WO2023275715A1 (en)	2021-06-30	2023-01-05	Pfizer Inc.	Metabolites of selective androgen receptor modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5501969A (en)	1994-03-08	1996-03-26	Human Genome Sciences, Inc.	Human osteoclast-derived cathepsin
WO1997047642A1 (en)	1996-06-14	1997-12-18	Smithkline Beecham Corporation	Cathepsin k gene

1995
- 1995-10-02 US US08/536,861 patent/US6544767B1/en not_active Expired - Fee Related
- 1995-10-26 CA CA002203765A patent/CA2203765C/en not_active Expired - Fee Related
- 1995-10-26 AT AT95937639T patent/ATE317441T1/de not_active IP Right Cessation
- 1995-10-26 HU HU9701942A patent/HU220960B1/hu not_active IP Right Cessation
- 1995-10-26 CN CNB951968416A patent/CN1148382C/zh not_active Expired - Fee Related
- 1995-10-26 DE DE69534778T patent/DE69534778T2/de not_active Expired - Fee Related
- 1995-10-26 NZ NZ296003A patent/NZ296003A/en unknown
- 1995-10-26 JP JP51472296A patent/JP3670666B2/ja not_active Expired - Fee Related
- 1995-10-26 ES ES95937639T patent/ES2256849T3/es not_active Expired - Lifetime
- 1995-10-26 KR KR1019970702787A patent/KR100473219B1/ko not_active Expired - Fee Related
- 1995-10-26 FI FI971777A patent/FI971777A0/fi not_active Application Discontinuation
- 1995-10-26 AU AU39688/95A patent/AU711810B2/en not_active Ceased
- 1995-10-26 WO PCT/US1995/013820 patent/WO1996013523A1/en active IP Right Grant
- 1995-10-26 EP EP95937639A patent/EP0783527B1/en not_active Revoked
1997
- 1997-04-23 NO NO971875A patent/NO971875L/no not_active Application Discontinuation
2002
- 2002-12-13 US US10/318,584 patent/US20030175937A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20030175937A1 (en)	2003-09-18
EP0783527A1 (en)	1997-07-16
DE69534778T2 (de)	2006-08-17
AU3968895A (en)	1996-05-23
CN1170415A (zh)	1998-01-14
CN1148382C (zh)	2004-05-05
FI971777A7 (fi)	1997-04-25
HU220960B1 (hu)	2002-07-29
EP0783527B1 (en)	2006-02-08
CA2203765A1 (en)	1996-05-09
CA2203765C (en)	2002-04-23
KR970707153A (ko)	1997-12-01
DE69534778D1 (en)	2006-04-20
NO971875D0 (no)	1997-04-23
WO1996013523A1 (en)	1996-05-09
NZ296003A (en)	1999-10-28
US6544767B1 (en)	2003-04-08
HUT77049A (hu)	1998-03-02
ES2256849T3 (es)	2006-07-16
EP0783527A4 (en)	1998-12-02
FI971777A0 (fi)	1997-04-25
JP3670666B2 (ja)	2005-07-13
NO971875L (no)	1997-06-12
ATE317441T1 (de)	2006-02-15
KR100473219B1 (ko)	2005-05-16
AU711810B2 (en)	1999-10-21
JPH10512740A (ja)	1998-12-08

Publication	Publication Date	Title
FI971777L (fi)	1997-04-25	Katepsiini O2-proteaasi
KR970701725A (ko)	1997-04-12	사람 파골세포 유래 카텝신(Human osteoclast-derived cathepsin)
FI954647L (fi)	1995-09-29	Proteaasimuunnokset
FI944033L (fi)	1994-09-02	Uusia proteaaseja
DK0778880T3 (da)	1999-06-23	Forbedret proteolytisk enzymrensemiddel
ID18001A (id)	1998-02-19	Penghambat-penghambat protease
NO944558D0 (no)	1994-11-28	Trykkveksler
DK0979240T3 (da)	2004-07-26	Serinproteaseinhibitor
DE69535069D1 (de)	2006-08-03	Vermittlungseinrichtung
FI951462A7 (fi)	1995-10-07	Paine-erokytkin
FI961350L (fi)	1996-03-25	Hapteenimerkityt peptidit
FI961097L (fi)	1996-03-08	Hapettumisenkestäviä proteaaseja
FI970168A7 (fi)	1997-01-15	Peptidejä
FI945163L (fi)	1995-05-04	Sieniproteaasi
DE69510273D1 (de)	1999-07-22	Schwimmflosse
FI964363L (fi)	1996-12-23	Peptidejä
DE69534544D1 (de)	2005-12-01	Vermittlungseinrichtung
FI940647A0 (fi)	1994-02-11	Parannetut erittäin alkaliset proteaasit
MA23665A1 (fr)	1996-04-01	Matllas gonflable
LV10836A (lv)	1995-10-20	Gofreta asinsvadu proteze
KR950026717U (ko)	1995-10-16	지압구
NO941200L (no)	1995-10-02	Trykkbryter
SE9400770D0 (sv)	1994-03-08	Integrerade knappar
KR960004318U (ko)	1996-02-14	소형화한 예금통장
KR950023915U (ko)	1995-08-23	플로우 스위치

Legal Events

Date	Code	Title	Description
2009-05-02	FD	Application lapsed